A new study may finally change how amyotrophic lateral sclerosis (ALS) is diagnosed. Scientists from UCLA Health and the ...
A new 3D human brain tissue platform developed by MIT researchers is the first to integrate all major brain cell types, ...
Purpose: This study aimed to evaluate abnormalities in the retinal nerve fiber layer and ganglion cell layer in patients with thyroid-associated orbitopathy using optical coherence tomography and to ...
In a study published in Neuron, a research team at the Department of Neurology at Massachusetts General Hospital, aimed to ...
Optic neuropathies including glaucoma, traumatic injury, ischemic damage, and optic neuritis, are the leading causes of irreversible blindness ...
Controlling the state of a cell in a desired direction is one of the central challenges in life sciences, including drug ...
Scientists are hoping to treat diseases including cancer and Alzheimer's by influencing how cells make life-or-death ...
A new, simple blood test developed by UCLA Health researchers shows promise in detecting amyotrophic lateral sclerosis (ALS) earlier and more accurately. This innovative test measures cell-free DNA, ...
Researchers have identified two forms of estrogen, estradiol and estriol, that may reduce inflammation and protect nerve fibers in progressive multiple sclerosis (MS).
An AI model used seven common clinical measures of inflammation, nutritional status, and more to predict ALS prognosis, a study reports.
A team of researchers at the University of Kentucky Sanders-Brown Center on Aging now have a better understanding of how the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results